A case of papillary thyroid carcinoma with renal and pulmonary metastases

被引：0

作者：

Aoyama, Mariko ^{[1
]}

Inui, Tomohiro ^{[1
]}

Miyamoto, Naoki ^{[1
]}

Sakamoto, Shinichi ^{[1
]}

Inoue, Seiya ^{[1
]}

Fujiwara, Satoshi ^{[1
]}

Goto, Masakazu ^{[1
]}

Toba, Hiroaki ^{[1
]}

Takizawa, Hiromitsu ^{[1
]}

机构：

[1] Univ Tokushima, Inst Hlth Biosci, Dept Thorac Endocrine Surg & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708509, Japan

来源：

JOURNAL OF SURGICAL CASE REPORTS | 2022年 / 2022卷 / 08期

关键词：

papillary thyroid carcinoma; renal metastasis; pulmonary metastasis; radioactive iodine therapy; lenvatinib; immune checkpoint inhibitor; LENVATINIB; CANCER;

D O I：

10.1093/jscr/rjac366

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Distant metastases derived from papillary carcinoma are generally detected in the lungs and bones. However, renal metastasis is rare. We herein report a case of papillary thyroid carcinoma with renal and pulmonary metastases that had been initially diagnosed as primary renal carcinoma with pulmonary metastases. The lesions showed response to immune checkpoint inhibitors and tyrosine kinase inhibitor but not to radioactive iodine therapy.

引用

页数：3

共 8 条

[1] Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy [J].

Durante, C. ;

Haddy, N. ;

Baudin, E. ;

Leboulleux, S. ;

Hartl, D. ;

Travagli, J. P. ;

Caillou, B. ;

Ricard, M. ;

Lumbroso, J. D. ;

De Vathaire, F. ;

Schlumberger, M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) :2892-2899

[2] Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer [J].

Mehnert, Janice M. ;

Varga, Andrea ;

Brose, Marcia S. ;

Aggarwal, Rahul R. ;

Lin, Chia-Chi ;

Prawira, Amy ;

de Braud, Filippo ;

Tamura, Kenji ;

Doi, Toshihiko ;

Piha-Paul, Sarina A. ;

Gilbert, Jill ;

Saraf, Sanatan ;

Thanigaimani, Pradeep ;

Cheng, Jonathan D. ;

Keam, Bhumsuk .

BMC CANCER, 2019, 19 (1)

[3] Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial [J].

Motzer, Robert J. ;

Hutson, Thomas E. ;

Glen, Hilary ;

Michaelson, M. Dror ;

Molina, Ana ;

Eisen, Timothy ;

Jassem, Jacek ;

Zolnierek, Jakub ;

Pablo Maroto, Jose ;

Mellado, Begona ;

Melichar, Bohuslav ;

Tomasek, Jiri ;

Kremer, Alton ;

Kim, Han-Joo ;

Wood, Karen ;

Dutcus, Corina ;

Larkin, James .

LANCET ONCOLOGY, 2015, 16 (15) :1473-1482

[4] Rare renal metastases from differentiated thyroid carcinoma: early clinical detection and treatment based on radioiodine [J].

Qiu, Zhong-Ling ;

Xue, Yan-Li ;

Luo, Quan-Yong p .

ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (03) :260-269

[5] Metastatic Papillary Thyroid Cancer to the Liver: The Central Role of a Multidisciplinary Approach to Treatment [J].

Riker, Adam, I ;

Hodgdon, Ian A. ;

Dewenter, Tracy A. ;

Marshall, Richard ;

Boulmay, Brian .

OCHSNER JOURNAL, 2021, 21 (02) :224-229

[6] Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer [J].

Schlumberger, Martin ;

Tahara, Makoto ;

Wirth, Lori J. ;

Robinson, Bruce ;

Brose, Marcia S. ;

Elisei, Rossella ;

Habra, Mouhammed Amir ;

Newbold, Kate ;

Shah, Manisha H. ;

Hoff, Ana O. ;

Gianoukakis, Andrew G. ;

Kiyota, Naomi ;

Taylor, Matthew H. ;

Kim, Sung-Bae ;

Krzyzanowska, Monika K. ;

Dutcus, Corina E. ;

de las Heras, Begona ;

Zhu, Junming ;

Sherman, Steven I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07) :621-630

[7]

Shaha AR, 1997, AM J SURG, V174, P474

[8] Rare metastases of differentiated thyroid carcinoma: pictorial review [J].

Song, Hong-Jun ;

Xue, Yan-Li ;

Xu, Yan-Hong ;

Qiu, Zhong-Ling ;

Luo, Quan-Yong .

← 1 →